← Eichor
Condition: Primary Graft Dysfunction Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Primary Graft Dysfunction

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction
Phase 2 · 1 location(s) · University of California, San Francisco · NCT06853223Prospective Reduction Of Transplant Complications Through Enhanced Preservation Therapy to Prevent Primary Graft Dysfunc
NA · 1 location(s) · University Health Network, Toronto · NCT07230886Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation
Phase N/A · 1 location(s) · University of Pennsylvania · NCT00552357Evaluation of Patients With Immune Function Abnormalities
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00128973Exhaled Breath Particles in Lung Transplantation
Phase N/A · 1 location(s) · Lund University Hospital · NCT05375149
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.